Integrated Transcriptomic and Spatial Analyses Associate M2-like Myeloid Signatures with Neuroimmune Remodeling in Alzheimer’s Disease
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27104430 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Sz-Bo Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, National Defense Medical University, Taipei 11490, Taiwan. Hauptthemen laut MEDLINE: Alzheimer Disease, Transcriptome, Macrophages, Myeloid Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Ministry of National Defense.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is characterized by progressive neurodegeneration and prominent neuroimmune remodeling, but the contribution of macrophage and myeloid states across disease severity remains incompletely defined. We integrated bulk transcriptomic, single-cell RNA sequencing (RNA-seq), and spatial transcriptomic datasets to characterize AD-associated myeloid immune changes across Braak stage and disease status. Across datasets, M2-like macrophage and myeloid signatures showed progressive enrichment with increasing neuropathological severity and were accompanied by pathway changes related to macrophage proliferation, TGF-β signaling, and myeloid homeostasis. Immune-feature-based classifiers identified macrophage-related variables among the informative features distinguishing AD from controls. CellChat analyses further inferred that M2-like myeloid populations occupied communication-enriched positions in single-cell and spatial interaction networks, including apolipoprotein E (ApoE), CX3C chemokine signaling, and fibronectin 1 (FN1)-associated signaling contexts. Collectively, these findings indicate that M2-like myeloid programs are consistently associated with AD severity and neuroimmune network remodeling. Rather than establishing a causal disease driver, this study highlights M2-like myeloid signatures as candidate neuroimmune components that warrant experimental validation in human-relevant systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, National Defense Medical University, Taipei 11490, Taiwan.
- Taipei Veterans General Hospital, Taipei 11217, Taiwan.
- Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei 11490, Taiwan.
- Graduate Institute of Biochemistry, College of Biomedical Science, National Defense Medical University, Taipei 11490, Taiwan.
ORCID-Profile: Yi-Lin Chiu
Förderung
- National Science and Technology Council
- Ministry of National Defense
Zitieren
APA
Wang, S. B., Chou, K. N., & Chiu, Y. L. (2026). Integrated Transcriptomic and Spatial Analyses Associate M2-like Myeloid Signatures with Neuroimmune Remodeling in Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27104430
Vancouver
Wang SB, Chou KN, Chiu YL. Integrated Transcriptomic and Spatial Analyses Associate M2-like Myeloid Signatures with Neuroimmune Remodeling in Alzheimer’s Disease. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27104430
BibTeX
@article{Wang2026,
author = {Wang, Sz-Bo and Chou, Kuan-Nien and Chiu, Yi-Lin},
title = {Integrated Transcriptomic and Spatial Analyses Associate M2-like Myeloid Signatures with Neuroimmune Remodeling in Alzheimer’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27104430}
}
EUVIMED